pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

US allocates $2 billion to faith-based health groups, highlighting shift toward faith-driven capital in global aid

Aug 20, 2026·read at STAT ↗Neutral

The Trump administration this month announced a nearly $2 billion allocation for faith‑based organizations, the largest such commitment in over two decades.

About $1.4 billion is earmarked for health services, including an $850 million award to World Vision to support roughly 2,500 faith‑run hospitals and clinics across 17 countries.

Dr. Alaa Murabit argues that while the traditional global health aid system is faltering, the “faith economy” – not just charities but the financial assets tied to religious institutions – is being positioned as both a delivery channel and a new source of capital for health initiatives.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: The global health aid architecture is collapsing. The faith economy isn’t”

read at STAT ↗
1,491 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
CYCLE
topics
Ophthalmology3Duchenne Muscular Dystrophy

related stories

  • 1d agoSTAT+: In wake of boy’s death, gene editing experts dissect Huidagene’s decisionsSTAT
  • 1d agoSTAT+: Nonprofit health system raked in $1.1 billion this year from stake in medical billing firmSTAT
  • Aug 12With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug developmentBioSpace
  • Aug 11Building Resilience for the Future of Biopharma InnovationFierce Biotech
  • Aug 54 potential biotech M&A targets, plus a pretty sure bet from J&JBioSpace